Symbol="CBAY"
AssetType="Common Stock"
Name="Cymabay Therapeu"
Description="CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering therapies to treat liver and other chronic diseases. The company is headquartered in Newark, California."
CIK="1042074"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3876 BAY CENTER PLACE, HAYWARD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1130178000"
EBITDA="-94744000"
PERatio="None"
PEGRatio="0"
BookValue="1.07"
DividendPerShare="0"
DividendYield="0"
EPS="-1.24"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.268"
ReturnOnEquityTTM="-1.012"
RevenueTTM="0"
GrossProfitTTM="-41635000"
DilutedEPSTTM="-1.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="14.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="5.76"
EVToRevenue="-"
EVToEBITDA="-3.032"
Beta="0.358"
num_52WeekHigh="12.25"
num_52WeekLow="2.95"
num_50DayMovingAverage="9.54"
num_200DayMovingAverage="7.14"
SharesOutstanding="97513000"
DividendDate="None"
ExDividendDate="None"
symbol="CBAY"
open="11.81"
high="11.93"
low="11.40"
price="11.59"
volume="1403502.00"
latest_trading_day="2023-07-14"
previous_close="11.82"
change="-0.23"
change_percent="-1.9459%"
aroon_positive_momentum_days="85"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="1882583"
Change_recent_avg="0.01"
Delta_recent_avg="0.49"
Variance_recent_avg="0.25"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="1125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0158.jpeg"
image_negative_thumbnail_id_2="1165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="659"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0049.jpeg"
image_positive_thumbnail_id_2="969"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0131.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
